Coexistence of adenomyosis in women operated for benign gynecological diseases

Özkan, Zehra Sema; Kumbak, Banu; Çilgin, Hasan; Şi̇mşek, Mehmet; Türk, Bilge

doi:10.3109/09513590.2011.593669

Cited by 14 publications

(13 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[83][84][85] The results for menorrhagia and dysmenorrhea have been less consistent when adenomyosis, or adenomyosis with leiomyomas, has been compared with those with pathology-confirmed leiomyomas. 12,43,[86][87][88][89][90][91][92][93] Although in several of these studies, patients with adenomyosis with or without leiomyomas appear to experience a greater frequency of dysmenorrhea than patients with leiomyomas. 12,86,87,90,92 One frequently cited study has suggested that adenomyosis is an incidental finding and not a source of symptoms.…”

Section: Symptomatologymentioning

confidence: 99%

Epidemiology of Adenomyosis

2020

View full text Add to dashboard Cite

Adenomyosis, characterized by the presence of endometrial glands and stroma within the myometrium, can have a substantial impact on the quality of women's lives. Despite this, the epidemiologic research on this condition lags considerably behind that of other noncancerous reproductive health conditions. The lack of progress and knowledge is due in part to the challenges in designing valid epidemiologic studies, since the diagnosis of adenomyosis historically has been limited to the examination of uterine specimens from hysterectomy. This review describes the available data on the frequency of this condition and the epidemiologic investigation thus far into the risk factors for disease—highlighting the methodologic and inference challenges primarily around study sample selection. We conclude with providing recommendations for approaches to future epidemiologic study that capitalize on the advancements in imaging technology to detect adenomyosis and provide a fuller picture of the occurrence and risk factors for disease.

show abstract

Section: Symptomatologymentioning

confidence: 99%

Epidemiology of Adenomyosis

2020

View full text Add to dashboard Cite

show abstract

“…The authors hypothesized that endomyometrial junction deterioration during endometrial sampling may be a trigger point for developing adenomyosis. 11 In another study also clinical and pathological correlation were poor, when DUB was the preoperative clinical diagnosis. Based on their observation here the authors suggested hysterectomy specimens should be sent for histopathology regardless of the preoperative histopathology of the endometrium.…”

Section: Discussionmentioning

confidence: 94%

Hysterectomy for dysfunctional uterine bleeding in the era of uterine conservation

Kaur

Pandey

Shine

2015

Int J Reprod Contracept Obstet Gynecol

View full text Add to dashboard Cite

“…Other researchers reported lower sensitivity, at 48 and 53% [70][71][72][73][74][75][76][77][78][79][80]. Other studies, with a larger number of women, are needed to address this issue [81][82][83][84][85].…”

Section: Diagnosismentioning

confidence: 99%

“…Magnetic resonance imaging (MRI) has been applied to pelvic pathology and the initial results in women with adenomyosis are encouraging [75][76][77][78][79][80][81][82][83][84]. Mark and his colleagues predicted adenomyosis in eight of 20 women studied with T2 images.…”

Section: Diagnosismentioning

confidence: 99%

See 1 more Smart Citation

Uterine Embolization as a New Treatment Option in Adenomyosis Uteri

Tsikouras¹,

Gaitatzi²,

Filiou³

et al. 2022

Endometriosis - Recent Advances, New Perspectives and Treatments

View full text Add to dashboard Cite

Adenomyosis is characterized by the development of endometrial ectopic glands and tissue in the myometrium layer in depth greater than 2.5 mm from the endometrial surface of the separative area by -myomas well as by hypertrophy and hyperplasia of the smooth muscles of the myometrium. This is filtration, not mere displacement, of the myometrium, from the endometrium. Clinical symptoms include dysmenorrhea and menorrhagia. It is diffuse (adenomyosis) or focal (adenomyoma), asymmetrically affects the uterine wall of premenopausal women (usually the posterior) and often coexists with myomas. The pathogenesis of adenomyosis remains unknown. The treatment options are: drug therapy, invasive treatment of fibroids: myomectomy (open—intra-abdominal, laparoscopic, hysteroscopic), hysterectomy, myolysis—cryocatalysis, microwave or radiofrequency thermal catalysis (RF-ablation), ultrasound focus catalysis (FUS), laser photocatalysis and percutaneous selective uterine artery embolization (UAE). Embolization remains an alternative and not a substitute of hysterectomy. The medical indication is made on a case-by-case basis, depending on age, desire for pregnancy and the clinical symptoms of adenomyosis.

show abstract

Coexistence of adenomyosis in women operated for benign gynecological diseases

Abstract: AG is an enigmatic disease frequently causing gynecologic complaints and endomyometrial junction deterioration during endometrial sampling may be a trigger point for developing AG.

Cited by 14 publications

References 24 publications

Epidemiology of Adenomyosis

Epidemiology of Adenomyosis

Hysterectomy for dysfunctional uterine bleeding in the era of uterine conservation

Uterine Embolization as a New Treatment Option in Adenomyosis Uteri

Contact Info

Product

Resources

About